Smiths Group (LON:SMIN) Stock Upgrade
In a recent report finalized on 1 December, HSBC raised the shares of Smiths Group (LON:SMIN) to a respectable Hold rating. They currently have a GBX 1000.00 PT on the stock. This PT indicates a possible downside of -3.19% from the closing share price of Smiths Group (LON:SMIN) shares.
From a total of 19 analysts covering Smiths Group (LON:SMIN) stock, 7 rate it a ”Buy”, 6 a “Sell”, and 5 a ”Hold”. This means that 39% of the ratings are positive. The highest target price is GBX 1450 while the lowest target price is GBX 845. The mean of all analyst targets is GBX 1095.26 with a 6.35% above today’s (GBX 1037.04) stock price. Smiths Group was the topic of 46 analyst reports since July 27, 2015 according to the firm StockzIntelligence Inc. RBC Capital Markets maintained shares on December 1 with “Underperform” rating. Panmure Gordon maintained shares with “Sell” rating and GBX 850 target share price in a report from a November 19. Citigroup maintained SMIN stock in a recent report from November 26 with “Buy” rating. Deutsche Bank maintained the rating on November 19. Deutsche Bank has a “Buy” rating and a GBX 1250 price target on shares. Finally, Nomura maintained the stock with “Buy” rating in a report issued on a November 20.
The stock increased 0.39% or GBX 4.04 on December 1, striking GBX 1037.04. Approximately 1.17M shares of stock traded hands. Smiths Group plc (LON:SMIN) has declined 8.91% since May 4, 2015 and is downtrending. It has underperformed by 7.28% the S&P500.
Smiths Group plc is a technology company. The company has a market cap of 4.09 billion GBP. The Firm operates through five divisions: John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect and Flex-Tek. It has 16.8 P/E ratio. John Crane division offers mechanical seals, seal support systems, engineered bearings, power transmission couplings and filtration systems.